The cardiovascular system medicine use in Belgium, expressed in Units (Defined Daily Dosage) Per Thousand Persons Per Day, experienced fluctuations over the past decade. From 2013 through 2023, there was a noticeable declining trend with minor recovering intervals. The value in 2023 stood at 488.4 units. Year-on-year variation from 2013 to 2023 revealed a mix of negative and positive changes, with substantial declines in 2017 and recoveries from 2019 onwards. Over the last two years, there was a steady increase with year-on-year percentages of 0.51% in 2023. The forecast up to 2028 indicates a gradual upward trend with a projected 5-year CAGR of 0.29%.

Future trends to watch for include:

• Potential impacts of new cardiovascular treatments and medications.
• The influence of demographic shifts such as an aging population.
• Changes in health policies and healthcare expenditure in Belgium.
• Advances in personalized medicine and digital health solutions.
• The overall lifestyle changes and awareness regarding cardiovascular health.